Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia

Details for Australian Patent Application No. 2003288451 (hide)

Owner Cambridge Biotechnology Limited

Inventors Richardson, Peter

Agent Shelston IP

Pub. Number AU-B-2003288451

PCT Number PCT/GB2003/0053

PCT Pub. Number WO2004/052377

Priority 0228723.3 09.12.02 GB

Filing date 9 December 2003

Wipo publication date 30 June 2004

Acceptance publication date 4 June 2009

International Classifications

A61K 31/7076 (2006.01)

A61K 31/197 (2006.01)

A61K 31/52 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 0228723.3 09.12.02 GB

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2003288451

4 June 2009 Application Accepted

  Published as AU-B-2003288451

1 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003288452-VACUUM PUMPING SYSTEM AND METHOD OF OPERATING A VACUUM PUMPING ARRANGEMENT

2003288450-VACUUM PUMPING ARRANGEMENT AND METHOD OF OPERATING SAME